نتایج جستجو برای: leucovorin

تعداد نتایج: 2615  

Journal: :The Journal of Experimental Medicine 1987
C J Allegra J A Kovacs J C Drake J C Swan B A Chabner H Masur

The therapy of Pneumocystis carinii (PC) pneumonia is often unsuccessful, particularly in patients with acquired immune deficiency syndrome (AIDS). Because of difficulties in growing the organism in vitro or obtaining purified organisms, current treatment choices have been made with little information on the metabolic effects of therapeutic agents on PC. This report quantitates the effects of t...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2012
Shouyu Wang Xuming Wu Yansu Chen Jianbing Zhang Jingjing Ding Yan Zhou Song He Yongfei Tan Fulin Qiang Jin Bai Jinyan Zeng Zhenghua Gong Aiping Li Gang Li Oluf Dimitri Røe Jianwei Zhou

PURPOSE To investigate the expression pattern and significance of DNA repair genes JWA and X-ray repair cross complement group 1 (XRCC1) in gastric cancer. EXPERIMENTAL DESIGN Expressions of JWA and XRCC1 were assessed by immunohistochemistry in a training cohort and they went into a second testing cohort and finally to a validating cohort. Prognostic and predictive role of JWA and XRCC1 expr...

Journal: :Anticancer research 2006
Chen-Hsi Hsieh Yu-Jen Chen Kou-Hwa Chang Hsi-Hsien Hsu Chien-Kuo Liu Shih-Kai Hung Hong-Wen Chen Yuen-Liang Lai Tzu-Chi Hsu

BACKGROUND This prospective, nonrandomized study was conducted to compare the efficacy and toxicity of post-operative concurrent chemoradiation therapy (CCRT) using daily oral uracil-tegafur plus leucovorin (UFUR/LV) vs. weekly intravenous fluorouracil plus leucovorin (5-FU/LV) in patients with locally advanced rectal cancer. MATERIALS AND METHODS From November 1996 through December 2004, 30 ...

Journal: :Annals of oncology : official journal of the European Society for Medical Oncology 2003
F Di Costanzo A Sobrero S Gasperoni L Dogliotti L Frassineti A Falcone R Lionetto P Bruzzi G Luppi L Gallo P Conte A Comandone D Turci M Marzola U Folco E Pfanner M Mestriner C Boni C Galli M Tonato R Rosso

BACKGROUND To determine whether the addition of leucovorin to the combination 5-fluorouracil plus levamisole prolongs disease-free survival and overall survival in patients with radically resected colon cancer (Dukes' B(2-3) and C). PATIENTS AND METHODS Patients (1703) were accrued between March 1992 and February 1995 in a large-scale clinical trial within five Italian cooperative groups. Aft...

2005
Janet A. Houghton David M. Tillman Franklin G. Harwood

In colon cancers induction of a thymineless state following inhibition of thymidylate synthase (TS) by 5-fluorouracil combined with leucovorin can initiate a cytotoxic response. Using a 5-fluorouracil-leucovorin-treated human colon carcinoma cell line (GC,Icl) and a clonally derived TS mutant, initiation events that dictate the onset of and commitment to thymineless death have been examined. In...

Journal: :The Journal of biological chemistry 2011
Sam Ogwang Hoa T Nguyen Marissa Sherman Saralee Bajaksouzian Michael R Jacobs W Henry Boom Guo-Fang Zhang Liem Nguyen

Antifolates, which are among the first antimicrobial agents invented, inhibit cell growth by creating an intracellular state of folate deficiency. Clinical resistance to antifolates has been mainly attributed to mutations that alter structure or expression of enzymes involved in de novo folate synthesis. We identified a Mycobacterium smegmatis mutant, named FUEL (which stands for folate utiliza...

Journal: :Annals of oncology : official journal of the European Society for Medical Oncology 2010
T Shimura N Fuse T Yoshino K Minashi M Tahara T Doi T Joh A Ohtsu

BACKGROUND Chemotherapy-induced interstitial lung disease (ILD) in colorectal cancer (CRC) patients is rarely reported, but its clinical features remain to be clarified. PATIENTS AND METHODS Using a computerized database, we retrospectively identified patients who developed ILD from 734 patients with CRC treated with infusional 5-fluorouracil, leucovorin and oxaliplatin (FOLFOX) or infusional...

Journal: :Annals of oncology : official journal of the European Society for Medical Oncology 2003
W Scheithauer J McKendrick S Begbie M Borner W I Burns H A Burris J Cassidy D Jodrell P Koralewski E L Levine N Marschner J Maroun P Garcia-Alfonso J Tujakowski G Van Hazel A Wong J Zaluski C Twelves

BACKGROUND Oral capecitabine achieves a superior response rate with an improved safety profile compared with bolus 5-fluorouracil-leucovorin (5-FU/LV) as first-line treatment for patients with metastatic colorectal cancer. We report here the results of a large phase III trial investigating adjuvant oral capecitabine compared with 5-FU/LV (Mayo Clinic regimen) in Dukes' C colon cancer. PATIENT...

Journal: :BMC Clinical Pharmacology 2006
Issa Dahabreh George Tsoutsos Dimitrios Tseligas Dimitrios Janinis

BACKGROUND Oxaliplatin is a platinum derivative, which is used in the treatment of colorectal cancer. A small number of oxaliplatin-related hemolytic and/or thrombocytopenic reactions have been reported. We present a case of hemolytic-uremic syndrome that developed during the 4th cycle of combination chemotherapy with oxaliplatin, 5-fluorouracil and leucovorin. CASE PRESENTATION A 52-year-old...

Journal: :Biomedical journal 2014
Hung-Ming Wang Cheng-Lung Hsu Chia-Hsun Hsieh Kang-Hsing Fan Chien-Yu Lin Joseph Tung-Chieh Chang Shiang-Fu Huang I-How Chen Chun-Ta Liao Shu-Kung Ng

BACKGROUND To evaluate the efficacy and adverse events of cisplatin, tegafur, and leucovorin concomitantly with radiotherapy for patients with advanced, non-metastatic squamous cell carcinoma (SCC) of the oropharynx and hypopharynx. METHODS The PTL regimen consisted of cisplatin (P) 50 mg/m 2 on day 1, oral tegafur (T) 800 mg/day plus leucovorin (LV) 60 mg/day on days 1 through 14. It was rep...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید